A Novel Plasmid DNA Technology (GTU®) Applied As A Potential HIV1/AIDS Therapeutic Vaccine

被引：0
|
作者：
Vardas, E. V. [1 ]
Gray, C. [1 ]
Stanescu, I. [1 ]
Blazevic, V. [1 ]
Valtavaara, M. [1 ]
Leinonen, M. [1 ]
机构：
[1] Univ Witwatersrand, Perinatal HIV Res Unit, Soweto, South Africa
来源：
VACCINE | 2008年
关键词：
HIV; Vaccine; GTU technology; Therapy;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 10 条
  • [1] DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS
    Lori, Franco
    EXPERT REVIEW OF VACCINES, 2011, 10 (10) : 1371 - 1384
  • [2] Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects
    Vardas, Eftyhia
    Stanescu, Ioana
    Leinonen, Mika
    Ellefsen, Kim
    Pantaleo, Giuseppe
    Valtavaara, Minna
    Ustav, Mart
    Reijonen, Kalevi
    VACCINE, 2012, 30 (27) : 4046 - 4054
  • [3] Therapeutic potential of an AcHERV-HPV L1 DNA vaccine
    Lee, Hee-Jung
    Yoon, Jong Kwang
    Heo, Yoonki
    Cho, Hansam
    Cho, Yeondong
    Gwon, Yongdae
    Kim, Kang Chang
    Choi, Jiwon
    Lee, Jae Sung
    Oh, Yu-Kyoung
    Kim, Young Bong
    JOURNAL OF MICROBIOLOGY, 2015, 53 (06) : 415 - 420
  • [4] Therapeutic potential of an AcHERV-HPV L1 DNA vaccine
    Hee-Jung Lee
    Jong Kwang Yoon
    Yoonki Heo
    Hansam Cho
    Yeondong Cho
    Yongdae Gwon
    Kang Chang Kim
    Jiwon Choi
    Jae Sung Lee
    Yu-Kyoung Oh
    Young Bong Kim
    Journal of Microbiology, 2015, 53 : 415 - 420
  • [5] Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection
    Swaminathan, Sanjay
    Dai, Luc
    Lane, H. Clifford
    Imamichi, Tomozumi
    CYTOKINE & GROWTH FACTOR REVIEWS, 2013, 24 (06) : 571 - 577
  • [6] Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs
    Shu, Yuuei
    Winfrey, Sarah
    Yang, Zhi-yong
    Xu, Ling
    Rao, Srinivas S.
    Srivastava, Indresh
    Barnett, Susan W.
    Nabel, Gary J.
    Mascola, John R.
    VACCINE, 2007, 25 (08) : 1398 - 1408
  • [7] A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice
    Li, XM
    Yang, XF
    Jiang, YY
    Liu, J
    INTERNATIONAL IMMUNOLOGY, 2005, 17 (10) : 1293 - 1302
  • [8] Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes
    Ayyavoo, V
    Kudchodkar, S
    Ramanathan, MP
    Le, P
    Muthumani, K
    Megalai, NM
    Dentchev, T
    Santiago-Barrios, L
    Mrinalini, C
    Weiner, DB
    AIDS, 2000, 14 (01) : 1 - 9
  • [9] DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge
    Nigam, Pragati
    Earl, Patricia L.
    Americo, Jeffrey L.
    Sharma, Sunita
    Wyatt, Linda S.
    Edghill-Spano, Yvette
    Chennareddi, Lakshmi S.
    Silvera, Peter
    Moss, Bernard
    Robinson, Harriet L.
    Amara, Rama Rao
    VIROLOGY, 2007, 366 (01) : 73 - 83
  • [10] ART-Treated Patients Exhibit an Adaptive Immune Response against the HFVAC Peptides, a Potential HIV-1 Therapeutic Vaccine (Provir/Latitude45 Study)
    Fleury, Herve
    Caldato, Sabrina
    Recordon-Pinson, Patricia
    Thebault, Patricia
    Guidicelli, Gwenda-Line
    Hessamfar, Mojgan
    Morlat, Philippe
    Bonnet, Fabrice
    Visentin, Jonathan
    VIRUSES-BASEL, 2020, 12 (11):
1